Pictet Asset Management Holding Sa Krystal Biotech, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 115,350 shares of KRYS stock, worth $18.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
115,350
Previous 137,433
16.07%
Holding current value
$18.3 Million
Previous $25.2 Million
16.89%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding KRYS
# of Institutions
310Shares Held
24.3MCall Options Held
483KPut Options Held
364K-
Black Rock Inc. New York, NY3.95MShares$626 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$452 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$416 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$230 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$157 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.07B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...